Initial clinical study terms to shorten by 1 to 2 years.

The initial clinical study terms for anti-cancer drugs seems to be shortened by one to two years.

The KFDA announced "Optimizing plan for non-clinical test data in the clinical study of anti-cancer drug" on Feb. 8 that to provide earlier chances of cancer treatments for the patients who have no other options with existing drugs, some terms of the initial clinical study for anti-cancer dr...